CorMedix (CRMD) announced it will be added to the Nasdaq Biotechnology Index (NBI). CorMedix’s addition to the NBI will become effective prior to the market open on Monday, December 23, 2024.
CorMedix (CRMD) announced it will be added to the Nasdaq Biotechnology Index (NBI). CorMedix’s addition to the NBI will become effective prior to the market open on Monday, December 23, 2024.